| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
| mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
| mRNA |
BRD-K02251932 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0005 |
| mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
| mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
| mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |